News

Medical Marketing & Media32m

Tariffs, drug pricing and GLP-1 wars dominate pharma’s Q2 earnings

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Eli Lilly First to Use Germany’s New Confidential Pricing for Mounjaro

Eli Lilly and Company (NYSE: LLY) is one of the best upside stocks to invest in now. On August 11, Eli Lilly announced its ...